Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end-stage kidney disease: A national cohort study. uri icon

authors

  • Ellenbogen, Michael I
  • Ardeshirrouhanifard, Shirin
  • Jodi Segal, MD, MPH
  • Streiff, Michael B
  • Deitelzweig, Steven B
  • Brotman, Daniel J

publication date

  • January 1, 2022